Background: During the COVID-19 pandemic period, healthcare systems substantially reorganized their management of several diseases, including acute cardiovascular diseases (ACVD) such as heart failure, stroke, myocardial infarction, and pulmonary embolism. While previous studies have reported changes in hospitalization rates and clinical outcomes, the economic impact of the pandemic on healthcare expenditures for patients with ACVD remains poorly documented. This study aimed to quantify disruptions in healthcare utilization and reimbursement trends among patients with ACVD in France during the pandemic period (2020-2023). Methods: Using comprehensive French healthcare reimbursement data from 2015 to 2023, this nationwide cohort study analyzed 3.9 million ACVD-related patient-years, totaling 86 billion euros in reimbursements. A two-step approach was employed: first, a linear regression model based on pre-pandemic trends (2015-2019) was used to project expected expenditures for the years 2020-2023, adjusting for age, sex, calendar year, and comorbidities. Second, expenditures observed during the years 2020-2023 were compared with these projections to estimate potential disruptions related to the pandemic period. Analyses were stratified across 21 expenditure categories. Results: Between 2020 and 2023, ACVD-related healthcare expenditures exceeded expected values by 2.3 billion euros (+6.2%), with the largest gap in 2023 (1.1 billion euros above projections). Notably, pre-pandemic annual expenditure growth (86-212 euros per patient) sharply accelerated during the pandemic period (492-1320 euros per patient). Excess spending was higher in males (1.4 billion euros), patients with severe comorbidities (>2 comorbidities: 1.4 billion euros), and in the 65,195 patients with ACVD and a history of a COVID-19-related hospitalization(s) (0.9 billion euros, driven primarily by short stay hospitalizations and rehabilitation care). Among non-COVID-19 ACVD patients, significant increases were observed in drug expenses, short stay hospitalizations, and hospitalizations in psychiatry. Conclusion: In France, the COVID-19 pandemic years were marked by substantial and sustained disruptions in healthcare expenditures among patients with ACVD, extending beyond care directly related to COVID-19. Excess costs were linked both to pandemic-related complications and broader systemic shifts, including increased psychiatric and rehabilitation needs. These findings have critical public health implications: they highlight the need to address ongoing healthcare system disruptions for this vulnerable population while also reinforcing vigilance in future health crises. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This work was supported by the Initiative Economie de la Sante of Sorbonne Universite (Idex Sorbonne Universite, programmes Investissements d'Avenir), and by the Ministere de la Solidarite et de la Sante (Programme de Recherche sur la Performance du Systeme des Soins, PREPS 20-0163). The sponsor and the funders had no role in study design, data collection and analysis, interpretation of data, decision to publish, or preparation of the manuscript. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The SNDS is a set of strictly anonymous databases comprising all mandatory national health insurance reimbursement data. Since June 30, 2021, INSERM has direct access to the SNDS. This permanent access is provided according French Decree No. 2016-1871 of December 26, 2016 relating to the processing of personal SNDS data and French law articles Art. R. 1461-1325 and 14. This study was declared prior to its initiation to the CepiDc-INSERM registry of studies requiring the use of the SNDS. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes According to the principles of data protection and French regulations, the authors cannot publicly release the data from the French National Health Data System (SNDS). However, any person or structure, public or private, for-profit or non-profit, can access SNDS data upon authorisation from the French Data Protection Office (CNIL, Commission Nationale de l'Informatique et des Libertes) to carry out a study, research, or an evaluation of public interest (https://www.snds.gouv.fr/SNDS/Contexte-et-perspectives-reglementaires#).
This paper examines how households adjust their non-medical consumption following major health deterioration, and the associated changes in healthcare utilization and out-of-pocket medical payments. It further investigates whether these responses are driven by financial constraints or by health-state dependence. Using pooled cross-sectional data on 21,007 households from the 2011 and 2017 waves of the French Household Budget Survey, a nationally representative survey covering nearly 900 consumption items linked to administrative income records, we examine how household budget allocations vary with out-of-pocket medical expenditures and hospitalization episodes, the latter serving as a proxy for major health deterioration. Higher out-of-pocket payments are associated with significant reductions in food, housing, transport and alcohol expenditure, whereas hospitalization is associated with limited consumption reallocations and does not modify the relationship between medical expenditures and consumption. Overall, the evidence is more consistent with a financial-constraint mechanism than with systematic preference changes induced by deteriorating health. Subgroup analyses show that consumption adjustments are particularly pronounced among low-income households and households composed exclusively of older individuals. These findings suggest that even in a system characterized by near-universal health insurance coverage, remaining out-of-pocket payments may generate meaningful welfare losses for financially vulnerable households, with potential implications for nutrition, mobility, and long-run living standards. JEL : D12; I14
Background: This presentation examines the results of a sociological study on the introduction of a flat-rate payment system for general practitioners within the PEPS pilot programme in France. The programme aims to enhance coordination between general practitioners and primary care nurses. Approach: The study is based on an evaluative sociological analysis using a qualitative methodology, which includes around forty semi-structured interviews. These interviews capture the views and practices of health professionals at the local level. The PEPS pilot programme is managed by the Ministry of Health and the National Health Insurance, following a co-constructive approach involving health professionals through regular consultations in the design and implementation process. Results: Over the past 15 years, integrated care policies have significantly evolved within primary care in France. A major shift came with the creation of multi-professional primary care groups in 2015, improving coordination among health professionals and introducing collective remuneration schemes. Traditionally, primary care in France has been organised around self-employed providers, compensated through fee-for-service payments. However, this model is seen by both administrative stakeholders and some providers as a barrier to interprofessional coordination, as it promotes competition between different practitioners. From 2019 to 2024, the PEPS pilot programme offered general practitioners in about 15 multi-professional primary care groups the option to replace individual fee-for-service payments with a collective flat-rate payment per patient. The aim of this payment system was to incentivise closer collaboration between GPs and nurses. The study focuses on two private primary care groups. Findings show that participating GPs share a distinct profile, often critical of fee-for-service payments, which in the French context symbolise professional autonomy for self-employed doctors. In these groups, the PEPS flat-rate payment initially reshaped professional practices, allowing doctors greater flexibility in patient care, such as adjusting consultation times based on needs. Additionally, the payment improved working conditions for self-employed practitioners by stabilising income. However, the PEPS payment does not automatically enhance coordination with other healthcare professionals. In the surveyed primary-care groups, GPs were already seeking to collaborate with other professionals, but the flat-rate payment did not necessarily advance this collaborative work. Most often, collaborative projects, such as prevention programmes or patient education initiatives, are supported by other funding sources rather than PEPS. Finally, one key challenge remains for the potential national implementation of the flat-rate payment: the collective distribution of the payment among GPs. While the surveyed primary-care groups found distribution methods that satisfied all professionals, 17 primary-care groups withdrew from the pilot programme due to internal conflicts over how to divide the collective payment. Implications: This research provides insights into the implementation of flat-rate payments aimed at improving coordinated patient care in primary settings. While it highlights the benefits of flat-rate payments for the working conditions of self-employed doctors in France, it shows limited evidence of significant improvements in integrated care across the surveyed primary care groups. These findings contribute to understanding the interactions between payment systems and the development of integrated care.
This article examines cohort, career-course, and feminization effects on general practitioners' (GPs) medical production. Using quasi-exhaustive French medico-administrative data collected every three years between 2005 and 2021, we estimate gender-specific intra- and intercohort trends in a standardized index of medical visits, while accounting for various contextual changes, such as patient aging and declining medical density. Our findings reveal that successive birth cohorts of GPs have exhibited increasingly higher levels of medical production, particularly among females, thereby narrowing the gender gap, although it persists even among the most recent cohorts. While feminization remains one of the key demographic shifts affecting current medical production, we show that the gender gap has significantly declined, albeit at an irregular pace, across cohorts of GPs who started their careers between the 1970s and the 2020s. Furthermore, as expected, intracohort trends in GP medical production follow an inverted U-shaped curve, although the production decline at the end of the career is less pronounced among female GPs. Overall, our results challenge common beliefs about younger generations of physicians and suggest that the current shortage of medical services is not related to a decline in the individual production among recently established young GPs, but remains essentially an issue of anticipating workforce needs.
BACKGROUND:Health is an essential component of climate adaptation and should be integrated into national policies to build resilient and effective systems. We aimed to review national climate adaptation policies to assess health integration globally, regionally, nationally, and sub-nationally. METHODS:In this global policy analysis, we systematically identified national climate adaptation policies for 198 countries in English and 14 other languages. We reviewed Health National Adaptation Plans (HNAPs), National Adaptation Plans (NAPs) or National Adaptation Programmes of Action (NAPAs) when NAPs did not exist, Nationally Determined Contributions (NDCs), and National Communications (NCs). We created a Python application to increase the accuracy of identification of health-related text and applied a standardised scoring metric that assessed five domains-health analysis, health-related actions, planned institutional leads, dedicated budgets and funding mechanisms, and measurement indicators for monitoring and evaluation (M&E)-to compare health integration across documents and countries. FINDINGS:197 countries, all except Libya, were found to have national climate adaptation policies (36 HNAPs, 123 NAPs or NAPAs, 200 NDCs, and 223 NCs). Across these policies, 458 (88% of 522 policies) mentioned health. 159 (81% of 197 countries) further referenced other national health policies. 191 (97%) identified populations disproportionately affected by climate change, whereas only 24 (12%) involved such populations in decision making. Six (3%) countries outlined budgets for health-related actions. Insufficient budgeting and fiscal planning emerged as the weakest aspects of health integration, and sexual and reproductive health and rights, allergies, injuries, violence, and mental health were found to be under-represented in policies. INTERPRETATION:Climate adaptation policies should be comprehensive and outline clear structures to translate plans into action. We need evidence-based inclusion of diseases and health conditions linked to concrete strategies, national and sub-national measurement to track progress, and designated leads to spearhead coordination. Involvement of disproportionately affected groups further bolsters policy relevance and equity, and adequate financing is central to ensuring implementation. FUNDING:None.